Glaucoma-- Sustained release/lasers

Join Dr. Bedrood as she reviews sustained release technologies as it relates to lowering of intraocular pressure in glaucoma patients and provides a historical perspective on glaucoma drugs, discussing the current sustained release platforms and the most recent data on them. This session will include an introduction to what is in the pipeline and what the future of glaucoma drugs looks like.

Dr. Samuelson will highlight the use of laser trabeculoplasty in the management of glaucoma including review of recent clinical trials in Europe and Africa supporting SLT for initial therapy. Novel strategies including the COAST Trial investigating annual, low dose laser therapy, and non-contract, “Direct SLT” (DSLT) currently in clinical trials will be featured. Finally, cyclophotocoagulation, image guided laser trabeculostomy, and updated recommendations for location of peripheral iridotomy will be addressed.